Sources

Every dose, warning and note in Doz is cited to a specific source with a section or page. Sources are official FDA labels on DailyMed, published guidelines and (once licensed) the medical school's licensed reference. Anything that cannot be verified is not entered.

FDA label (DailyMed)

  • FDA Amoxicillin — Amoxicillin tablets, for oral suspension, chewable tablets and capsules — Prescribing Information (SPL effective 2026-10-06, version 4)↗[Public]
  • FDA Augmentin — AUGMENTIN (amoxicillin/clavulanate potassium) tablets, powder for oral suspension and chewable tablets — Prescribing Information (SPL effective 2016-09-01, version 6)↗[Public]
  • FDA Augmentin ES-600 — AUGMENTIN ES-600 (amoxicillin/clavulanate potassium) for oral suspension — Prescribing Information (SPL effective 2026-07-07, version 6)↗[Public]
  • FDA Zithromax — ZITHROMAX (azithromycin) tablets and oral suspension — Prescribing Information (SPL effective 2026-07-24, version 49)↗[Public]
  • FDA Risperdal — RISPERDAL (risperidone) tablets, oral solution and M-TAB orally disintegrating tablets — Prescribing Information (SPL effective 2026-05-28, version 45)↗[Public]
  • FDA Lactulose — Lactulose Solution USP (10 g/15 mL), Rx — Prescribing Information (SPL effective 2026-08-17, version 1)↗[Public]
  • FDA Ibuprofen Rx — Ibuprofen Oral Suspension USP 100 mg/5 mL, Rx only — Prescribing Information (SPL effective 2026-03-30, version 1)↗[Public]
  • FDA Ibuprofen OTC — Children's Ibuprofen Oral Suspension USP 100 mg/5 mL — Drug Facts (SPL effective 2026-07-15, version 1)↗[Public]
  • FDA Cetirizine OTC — Children's Cetirizine Hydrochloride Oral Solution 5 mg/5 mL — Drug Facts (SPL effective 2026-09-25, version 4)↗[Public]
  • FDA Guaif-Codeine OTC — Guaifenesin and Codeine Phosphate oral solution — Drug Facts (SPL effective 2026-06-02, version 5)↗[Public]
  • FDA Cephalexin — Cephalexin for oral suspension — Prescribing Information (SPL effective 2026-09-02, version 1)↗[Public]
  • FDA Cefixime — Cefixime for oral suspension and capsules — Prescribing Information (SPL effective 2025-10-14, version 14)↗[Public]
  • FDA Cefuroxime susp — Cefuroxime axetil for oral suspension — Prescribing Information (SPL effective 2013-08-19, version 1)↗[Public]
  • FDA Clarithromycin susp — Clarithromycin for oral suspension — Prescribing Information (SPL effective 2023-09-13, version 15)↗[Public]
  • FDA Clarithromycin tab — Clarithromycin tablets — Prescribing Information (SPL effective 2025-06-09, version 15)↗[Public]
  • FDA Cleocin Pediatric — CLEOCIN PEDIATRIC (clindamycin palmitate HCl) granules for oral solution — Prescribing Information (SPL effective 2026-06-01, version 35)↗[Public]
  • FDA Erythromycin ES — Erythromycin ethylsuccinate for oral suspension — Prescribing Information (SPL effective 2025-06-20, version 3)↗[Public]
  • FDA TMP-SMX susp — Sulfamethoxazole and trimethoprim oral suspension — Prescribing Information (SPL effective 2026-04-06, version 7)↗[Public]
  • FDA Famotidine susp — Famotidine for oral suspension 40 mg/5 mL — Prescribing Information (SPL effective 2026-08-04, version 1)↗[Public]
  • FDA Alinia — ALINIA (nitazoxanide) tablets and oral suspension — Prescribing Information (SPL effective 2024-03-20, version 10)↗[Public]
  • FDA Ondansetron — Ondansetron tablets — Prescribing Information (SPL effective 2026-10-12, version 14)↗[Public]
  • FDA Children's Benadryl — Children's Benadryl Allergy (diphenhydramine HCl 12.5 mg/5 mL) — Drug Facts (SPL effective 2026-09-11, version 15)↗[Public]
  • FDA Loratadine OTC — Children's Allergy Relief (loratadine 5 mg/5 mL oral solution) — Drug Facts (SPL effective 2026-09-04, version 4)↗[Public]
  • FDA Fexofenadine OTC — Fexofenadine HCl 30 mg/5 mL oral suspension — Drug Facts (SPL effective 2026-09-01, version 1)↗[Public]
  • FDA Hydroxyzine — Hydroxyzine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Desloratadine — Desloratadine tablets 5 mg — Prescribing Information (SPL effective 2026-04-16, version 12)↗[Public]
  • FDA Children's Tylenol — Children's Tylenol (acetaminophen 160 mg/5 mL oral suspension) — Drug Facts (SPL effective 2026-06-12, version 3)↗[Public]
  • FDA Mefenamic acid — Mefenamic acid capsules 250 mg — Prescribing Information (SPL effective 2026-04-20, version 13)↗[Public]
  • FDA Theophylline sol — Theophylline Oral Solution 80 mg/15 mL — Prescribing Information (SPL effective 2026-02-06, version 4)↗[Public]
  • FDA Nystatin susp — Nystatin Oral Suspension 100,000 units/mL — Prescribing Information (SPL effective 2026-10-09, version 4)↗[Public]
  • FDA Metronidazole — Metronidazole tablets — Prescribing Information (SPL effective 2026-09-10, version 10)↗[Public]
  • FDA Dicyclomine — Dicyclomine hydrochloride tablets — Prescribing Information (SPL effective 2026-10-13, version 1)↗[Public]
  • FDA Oseltamivir susp — Oseltamivir phosphate for oral suspension 6 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 14)↗[Public]
  • FDA Emverm — EMVERM (mebendazole) chewable tablet 100 mg — Prescribing Information (SPL effective 2021-08-23, version 11)↗[Public]
  • FDA Albenza — ALBENZA (albendazole) tablets — Prescribing Information (SPL effective 2019-09-23, version 14)↗[Public]
  • FDA Acyclovir susp — Acyclovir Oral Suspension 200 mg/5 mL — Prescribing Information (SPL effective 2026-01-23, version 4)↗[Public]
  • FDA Montelukast — Montelukast sodium tablets, chewable tablets and oral granules — Prescribing Information (SPL effective 2026-07-28, version 24)↗[Public]
  • FDA Ventolin HFA — VENTOLIN HFA (albuterol sulfate) inhalation aerosol — Prescribing Information (SPL effective 2026-09-24, version 15)↗[Public]
  • FDA Permethrin 5% — Permethrin cream 5% — Prescribing Information (SPL effective 2026-07-24, version 3)↗[Public]
  • FDA Prednisolone sol — Prednisolone sodium phosphate oral solution 25 mg/5 mL — Prescribing Information (SPL effective 2025-12-03, version 8)↗[Public]
  • FDA Dexa Intensol — Dexamethasone Oral Solution USP Intensol (concentrate) 1 mg/mL — Prescribing Information (SPL effective 2026-08-21, version 1)↗[Public]
  • FDA Delsym — DELSYM (dextromethorphan polistirex) extended-release suspension — Drug Facts (SPL effective 2026-09-09, version 15)↗[Public]
  • FDA Children's Sudafed — Children's Sudafed Nasal Decongestant (pseudoephedrine HCl 15 mg/5 mL) — Drug Facts (SPL effective 2024-11-08, version 9)↗[Public]
  • FDA Guaifenesin OTC — Max Tussin Mucus and Chest Congestion (guaifenesin 200 mg/10 mL) — Drug Facts (SPL effective 2026-08-31, version 5)↗[Public]
  • FDA Omeprazole — Omeprazole delayed-release capsules — Prescribing Information (SPL effective 2026-09-01, version 1)↗[Public]
  • FDA Protonix — PROTONIX (pantoprazole) delayed-release tablets and oral suspension — Prescribing Information (SPL effective 2026-05-18, version 48)↗[Public]
  • FDA Metformin — Metformin hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Atorvastatin — Atorvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-08, version 4)↗[Public]
  • FDA Losartan — Losartan potassium tablets — Prescribing Information (SPL effective 2026-09-29, version 17)↗[Public]
  • FDA Amlodipine — Amlodipine besylate tablets — Prescribing Information (SPL effective 2026-10-09, version 18)↗[Public]
  • FDA Levothyroxine — Levothyroxine sodium tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[Public]
  • FDA Diclofenac DR — Diclofenac sodium delayed-release tablets — Prescribing Information (SPL effective 2026-09-24, version 1)↗[Public]
  • FDA Ritalin — RITALIN (methylphenidate HCl) tablets — Prescribing Information (SPL effective 2025-02-05, version 3)↗[Public]
  • FDA Sertraline — Sertraline hydrochloride tablets — Prescribing Information (SPL effective 2026-09-17, version 10)↗[Public]
  • FDA Fluoxetine — Fluoxetine capsules — Prescribing Information (SPL effective 2026-10-02, version 1)↗[Public]
  • FDA Celexa — CELEXA (citalopram) tablets — Prescribing Information (SPL effective 2023-10-09, version 40)↗[Public]
  • FDA Aripiprazole — Aripiprazole tablets — Prescribing Information (SPL effective 2026-10-05, version 6)↗[Public]
  • FDA Divalproex — Divalproex sodium delayed-release tablets — Prescribing Information (SPL effective 2026-10-07, version 1)↗[Public]
  • FDA Lithium — Lithium carbonate tablets and capsules — Prescribing Information (SPL effective 2026-08-16, version 3)↗[Public]
  • FDA Lexapro — LEXAPRO (escitalopram) tablets — Prescribing Information (SPL effective 2023-10-01, version 45)↗[Public]
  • FDA Escitalopram — Escitalopram tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Quetiapine — Quetiapine tablets — Prescribing Information (SPL effective 2026-09-17, version 9)↗[Public]
  • FDA Zyprexa — ZYPREXA (olanzapine) tablets — Prescribing Information (SPL effective 2026-10-06, version 69)↗[Public]
  • FDA Clonazepam — Clonazepam tablets — Prescribing Information (SPL effective 2026-10-06, version 1)↗[Public]
  • FDA Xanax — XANAX (alprazolam) tablets — Prescribing Information (SPL effective 2024-04-15, version 5)↗[Public]
  • FDA Atomoxetine — Atomoxetine capsules — Prescribing Information (SPL effective 2026-09-29, version 9)↗[Public]
  • FDA Carbamazepine — Carbamazepine tablets — Prescribing Information (SPL effective 2026-10-12, version 1)↗[Public]
  • FDA Bupropion XL — Bupropion hydrochloride extended-release tablets (XL) — Prescribing Information (SPL effective 2026-07-16, version 42)↗[Public]
  • FDA Venlafaxine XR — Venlafaxine hydrochloride extended-release capsules — Prescribing Information (SPL effective 2026-10-05, version 2)↗[Public]
  • FDA Mirtazapine — Mirtazapine tablets — Prescribing Information (SPL effective 2026-10-06, version 13)↗[Public]
  • FDA Trazodone — Trazodone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-12, version 4)↗[Public]
  • FDA Buspirone — Buspirone hydrochloride tablets — Prescribing Information (SPL effective 2026-10-10, version 1)↗[Public]
  • FDA Haloperidol — Haloperidol tablets — Prescribing Information (SPL effective 2026-09-02, version 3)↗[Public]
  • FDA Rizatriptan ODT — Rizatriptan benzoate orally disintegrating tablets — Prescribing Information (SPL effective 2026-10-09, version 14)↗[Public]
  • FDA Sumatriptan — Sumatriptan tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Topiramate — Topiramate tablets — Prescribing Information (SPL effective 2026-10-13, version 17)↗[Public]
  • FDA Propranolol — Propranolol hydrochloride tablets — Prescribing Information (SPL effective 2026-10-09, version 8)↗[Public]
  • FDA Tobramycin eye — Tobramycin ophthalmic solution USP 0.3% — Prescribing Information (SPL effective 2024-06-14, version 1)↗[Public]
  • FDA Cipro eye drops — Ciprofloxacin ophthalmic solution 0.3% — Prescribing Information (SPL effective 2026-05-05, version 2)↗[Public]
  • FDA Erythromycin eye — Erythromycin ophthalmic ointment USP 0.5% — Prescribing Information (SPL effective 2026-08-28, version 12)↗[Public]
  • FDA Pataday (OTC) — Pataday Twice Daily Relief (olopatadine 0.1%) — Drug Facts (SPL effective 2026-01-20, version 6)↗[Public]
  • FDA Ketotifen eye (OTC) — Ketotifen fumarate ophthalmic solution 0.025% — Drug Facts (SPL effective 2026-04-15, version 1)↗[Public]
  • FDA Enalapril — Enalapril maleate tablets USP — Prescribing Information (SPL effective 2026-09-16, version 3)↗[Public]
  • FDA Captopril — Captopril tablets USP — Prescribing Information (SPL effective 2026-09-14, version 4)↗[Public]
  • FDA Valsartan — Valsartan tablets USP — Prescribing Information (SPL effective 2026-08-25, version 23)↗[Public]
  • FDA Metoprolol tartrate — Metoprolol tartrate tablets USP — Prescribing Information (SPL effective 2026-09-29, version 1)↗[Public]
  • FDA Atenolol — Atenolol tablets USP — Prescribing Information (SPL effective 2026-09-28, version 13)↗[Public]
  • FDA Carvedilol — Carvedilol tablets — Prescribing Information (SPL effective 2026-10-06, version 8)↗[Public]
  • FDA Hydrochlorothiazide — Hydrochlorothiazide tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[Public]
  • FDA Furosemide tabs — Furosemide tablets USP — Prescribing Information (SPL effective 2026-06-18, version 4)↗[Public]
  • FDA Furosemide solution — Furosemide oral solution USP 10 mg/mL — Prescribing Information (SPL effective 2026-06-23, version 1)↗[Public]
  • FDA Spironolactone — Spironolactone tablets USP — Prescribing Information (SPL effective 2026-10-07, version 10)↗[Public]
  • FDA Simvastatin — Simvastatin tablets USP — Prescribing Information (SPL effective 2026-08-31, version 4)↗[Public]
  • FDA Rosuvastatin — Rosuvastatin calcium tablets — Prescribing Information (SPL effective 2026-10-06, version 9)↗[Public]
  • FDA Crestor — Crestor (rosuvastatin) tablets — Prescribing Information (SPL effective 2026-09-23, version 19)↗[Public]
  • FDA Clopidogrel — Clopidogrel tablets USP — Prescribing Information (SPL effective 2026-09-29, version 8)↗[Public]
  • FDA Warfarin — Warfarin sodium tablets USP — Prescribing Information (SPL effective 2026-10-06, version 6)↗[Public]
  • FDA Isosorbide dinitrate — Isosorbide dinitrate tablets USP — Prescribing Information (SPL effective 2026-07-31, version 18)↗[Public]
  • FDA Digoxin — Digoxin tablets USP — Prescribing Information (SPL effective 2026-01-13, version 20)↗[Public]
  • FDA Nitroglycerin SL — Nitroglycerin sublingual tablets USP — Prescribing Information (SPL effective 2026-09-03, version 5)↗[Public]
  • FDA Aspirin 81 (OTC) — Aspirin 81 mg chewable tablets — Drug Facts (SPL effective 2026-10-06, version 2)↗[Public]
  • FDA Glyburide — Glyburide (glibenclamide) tablets USP — Prescribing Information (SPL effective 2015-05-01, version 19)↗[Public]
  • FDA Glimepiride — Glimepiride tablets USP — Prescribing Information (SPL effective 2026-09-24, version 1)↗[Public]
  • FDA Glipizide — Glipizide tablets USP — Prescribing Information (SPL effective 2026-10-13, version 17)↗[Public]
  • FDA Sitagliptin — Sitagliptin tablets — Prescribing Information (SPL effective 2026-09-16, version 3)↗[Public]
  • FDA Jardiance — Jardiance (empagliflozin) tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[Public]
  • FDA Pioglitazone — Pioglitazone tablets USP — Prescribing Information (SPL effective 2025-03-05, version 1)↗[Public]
  • FDA Pioglitazone (2) — Pioglitazone tablets — Prescribing Information (SPL effective 2026-09-15, version 2)↗[Public]
  • FDA Methimazole — Methimazole tablets USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[Public]
  • FDA Propylthiouracil — Propylthiouracil tablets USP — Prescribing Information (SPL effective 2026-08-25, version 18)↗[Public]
  • FDA Humulin R — Humulin R (insulin human) U-100 injection — Prescribing Information (SPL effective 2026-06-16, version 35)↗[Public]
  • FDA Macrobid — Macrobid (nitrofurantoin monohydrate/macrocrystals) capsules — Prescribing Information (SPL effective 2025-10-14, version 27)↗[Public]
  • FDA Nitrofurantoin macro — Nitrofurantoin capsules USP (macrocrystals) — Prescribing Information (SPL effective 2026-04-23, version 5)↗[Public]
  • FDA Nitrofurantoin susp — Nitrofurantoin oral suspension 25 mg/5 mL — Prescribing Information (SPL effective 2025-11-11, version 5)↗[Public]
  • FDA Ciprofloxacin — Ciprofloxacin tablets USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[Public]
  • FDA Levofloxacin — Levofloxacin tablets USP — Prescribing Information (SPL effective 2026-08-21, version 7)↗[Public]
  • FDA Doxycycline — Doxycycline hyclate tablets USP — Prescribing Information (SPL effective 2026-10-06, version 2)↗[Public]
  • FDA Ceftriaxone — Ceftriaxone for injection USP — Prescribing Information (SPL effective 2026-09-30, version 18)↗[Public]
  • FDA Bicillin L-A — Bicillin L-A (penicillin G benzathine injectable suspension) — Prescribing Information (SPL effective 2026-07-21, version 35)↗[Public]
  • FDA Diflucan — Diflucan (fluconazole) tablets and oral suspension — Prescribing Information (SPL effective 2026-04-02, version 57)↗[Public]
  • FDA Terbinafine — Terbinafine tablets — Prescribing Information (SPL effective 2026-07-09, version 7)↗[Public]
  • FDA Valacyclovir — Valacyclovir tablets USP — Prescribing Information (SPL effective 2026-09-10, version 3)↗[Public]
  • FDA Valacyclovir 1 g — Valacyclovir hydrochloride tablets (500 mg, 1 g) — Prescribing Information (SPL effective 2026-08-13, version 6)↗[Public]
  • FDA Cefdinir susp — Cefdinir for oral suspension USP — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Naproxen — Naproxen tablets USP — Prescribing Information (SPL effective 2026-10-08, version 12)↗[Public]
  • FDA Celecoxib — Celecoxib capsules — Prescribing Information (SPL effective 2025-04-01, version 22)↗[Public]
  • FDA Meloxicam — Meloxicam tablets USP — Prescribing Information (SPL effective 2026-10-02, version 2)↗[Public]
  • FDA Tramadol — Tramadol hydrochloride tablets USP — Prescribing Information (SPL effective 2026-10-12, version 5)↗[Public]
  • FDA Methocarbamol — Methocarbamol tablets USP — Prescribing Information (SPL effective 2026-10-07, version 7)↗[Public]
  • FDA Baclofen — Baclofen tablets USP — Prescribing Information (SPL effective 2026-08-24, version 24)↗[Public]
  • FDA Baclofen (2) — Baclofen tablets USP 20 mg — Prescribing Information (SPL effective 2026-10-09, version 4)↗[Public]
  • FDA Colcrys — Colcrys (colchicine) tablets — Prescribing Information (SPL effective 2022-10-01, version 4)↗[Public]
  • FDA Allopurinol — Allopurinol tablets — Prescribing Information (SPL effective 2026-10-09, version 1)↗[Public]
  • FDA Amitriptyline — Amitriptyline hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-08, version 10)↗[Public]
  • FDA Nortriptyline — Nortriptyline hydrochloride capsules USP — Prescribing Information (SPL effective 2026-09-28, version 2)↗[Public]
  • FDA Neurontin — Neurontin (gabapentin) capsules, tablets, oral solution — Prescribing Information (SPL effective 2026-05-12, version 48)↗[Public]
  • FDA Gabapentin — Gabapentin capsules USP — Prescribing Information (SPL effective 2026-10-08, version 2)↗[Public]
  • FDA Lyrica — Lyrica (pregabalin) capsules and oral solution — Prescribing Information (SPL effective 2025-04-15, version 18)↗[Public]
  • FDA Pregabalin — Pregabalin capsules — Prescribing Information (SPL effective 2026-09-30, version 13)↗[Public]
  • FDA Lamotrigine — Lamotrigine tablets / ODT — Prescribing Information (SPL effective 2026-09-24, version 8)↗[Public]
  • FDA Levetiracetam tabs — Levetiracetam tablets USP — Prescribing Information (SPL effective 2026-09-11, version 1)↗[Public]
  • FDA Levetiracetam sol — Levetiracetam oral solution 100 mg/mL — Prescribing Information (SPL effective 2026-09-22, version 27)↗[Public]
  • FDA Phenytoin ER — Extended phenytoin sodium capsules USP — Prescribing Information (SPL effective 2026-08-20, version 2)↗[Public]
  • FDA Phenytoin susp — Phenytoin oral suspension 125 mg/5 mL — Prescribing Information (SPL effective 2025-08-19, version 17)↗[Public]
  • FDA Diazepam — Diazepam tablets USP — Prescribing Information (SPL effective 2023-04-04, version 17)↗[Public]
  • FDA Lorazepam — Lorazepam tablets USP — Prescribing Information (SPL effective 2026-09-30, version 17)↗[Public]
  • FDA Zolpidem — Zolpidem tartrate tablets — Prescribing Information (SPL effective 2026-09-01, version 27)↗[Public]
  • FDA Promethazine — Promethazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-10, version 4)↗[Public]
  • FDA Dimenhydrinate (OTC) — Dimenhydrinate 50 mg tablets — Drug Facts (SPL effective 2026-09-30, version 13)↗[Public]
  • FDA Meclizine (OTC) — Meclizine HCl 25 mg tablets — Drug Facts (SPL effective 2026-10-05, version 2)↗[Public]
  • FDA Loperamide (OTC) — Loperamide HCl 2 mg caplets — Drug Facts (SPL effective 2026-10-01, version 10)↗[Public]
  • FDA Bisacodyl (OTC) — Bisacodyl 5 mg tablets — Drug Facts (SPL effective 2026-09-18, version 1)↗[Public]
  • FDA Simethicone drops — Infants' gas relief drops (simethicone 20 mg/0.3 mL) — Drug Facts (SPL effective 2026-10-01, version 8)↗[Public]
  • FDA Simethicone 125 — Simethicone 125 mg softgels — Drug Facts (SPL effective 2026-10-08, version 5)↗[Public]
  • FDA Fluticasone nasal — Fluticasone propionate nasal spray USP 50 mcg — Prescribing Information (SPL effective 2026-09-24, version 12)↗[Public]
  • FDA Atrovent HFA — Atrovent HFA (ipratropium bromide) inhalation aerosol — Prescribing Information (SPL effective 2025-11-05, version 21)↗[Public]
  • FDA Tamsulosin — Tamsulosin hydrochloride capsules — Prescribing Information (SPL effective 2026-09-01, version 4)↗[Public]
  • FDA Oxybutynin — Oxybutynin chloride tablets USP — Prescribing Information (SPL effective 2026-07-21, version 2)↗[Public]
  • FDA Hydrocortisone 1% — Hydrocortisone 1% anti-itch cream — Drug Facts (SPL effective 2026-10-08, version 5)↗[Public]
  • FDA Betamethasone val. — Betamethasone valerate ointment USP 0.1% — Prescribing Information (SPL effective 2026-03-19, version 5)↗[Public]
  • FDA Mupirocin — Mupirocin ointment USP 2% — Prescribing Information (SPL effective 2026-08-20, version 4)↗[Public]
  • FDA Ketoconazole cream — Ketoconazole cream 2% — Prescribing Information (SPL effective 2026-09-18, version 6)↗[Public]
  • FDA Silver sulfadiazine — Silver sulfadiazine cream USP 1% — Prescribing Information (SPL effective 2026-07-13, version 10)↗[Public]
  • FDA Medroxyprogesterone — Medroxyprogesterone acetate tablets USP — Prescribing Information (SPL effective 2026-09-25, version 7)↗[Public]
  • FDA Lisinopril — Lisinopril tablets USP — Prescribing Information (SPL effective 2026-10-07, version 12)↗[Public]
  • FDA Ramipril — Ramipril capsules USP — Prescribing Information (SPL effective 2026-09-18, version 19)↗[Public]
  • FDA Irbesartan — Irbesartan tablets USP — Prescribing Information (SPL effective 2026-08-06, version 13)↗[Public]
  • FDA Telmisartan — Telmisartan tablets USP — Prescribing Information (SPL effective 2026-05-29, version 3)↗[Public]
  • FDA Bisoprolol — Bisoprolol fumarate tablets USP — Prescribing Information (SPL effective 2025-11-12, version 3)↗[Public]
  • FDA Procardia XL — Procardia XL (nifedipine) extended-release tablets — Prescribing Information (SPL effective 2026-09-21, version 20)↗[Public]
  • FDA Diltiazem — Diltiazem hydrochloride tablets USP — Prescribing Information (SPL effective 2025-05-05, version 1)↗[Public]
  • FDA Hydralazine — Hydralazine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-02-02, version 13)↗[Public]
  • FDA Chlorthalidone — Chlorthalidone tablets USP — Prescribing Information (SPL effective 2026-09-21, version 2)↗[Public]
  • FDA Ezetimibe — Ezetimibe tablets USP — Prescribing Information (SPL effective 2026-01-13, version 6)↗[Public]
  • FDA Fenofibrate — Fenofibrate tablets 54/160 mg — Prescribing Information (SPL effective 2026-09-29, version 9)↗[Public]
  • FDA Eliquis — Eliquis (apixaban) tablets — Prescribing Information (SPL effective 2025-04-17, version 30)↗[Public]
  • FDA Xarelto — Xarelto (rivaroxaban) tablets — Prescribing Information (SPL effective 2026-09-10, version 65)↗[Public]
  • FDA Farxiga — Farxiga (dapagliflozin) tablets — Prescribing Information (SPL effective 2026-06-03, version 49)↗[Public]
  • FDA Alendronate — Alendronate sodium tablets USP — Prescribing Information (SPL effective 2026-06-12, version 17)↗[Public]
  • FDA Lantus — Lantus (insulin glargine) injection — Prescribing Information (SPL effective 2025-06-02, version 35)↗[Public]
  • FDA Penicillin VK — Penicillin V potassium tablets and oral solution — Prescribing Information (SPL effective 2023-01-31, version 15)↗[Public]
  • FDA Cefadroxil caps — Cefadroxil capsules USP — Prescribing Information (SPL effective 2025-10-10, version 8)↗[Public]
  • FDA Cefadroxil susp — Cefadroxil for oral suspension USP — Prescribing Information (SPL effective 2025-10-08, version 9)↗[Public]
  • FDA Fosfomycin — Fosfomycin tromethamine granules for oral solution — Prescribing Information (SPL effective 2026-09-10, version 2)↗[Public]
  • FDA Tinidazole — Tinidazole tablets — Prescribing Information (SPL effective 2025-12-17, version 9)↗[Public]
  • FDA Griseofulvin susp — Griseofulvin oral suspension (microsize) — Prescribing Information (SPL effective 2023-09-30, version 17)↗[Public]
  • FDA Itraconazole — Itraconazole capsules — Prescribing Information (SPL effective 2026-09-17, version 27)↗[Public]
  • FDA Ivermectin — Ivermectin tablets USP 3 mg — Prescribing Information (SPL effective 2024-08-28, version 3)↗[Public]
  • FDA Biltricide — Biltricide (praziquantel) tablets — Prescribing Information (SPL effective 2026-03-02, version 13)↗[Public]
  • FDA Pyrantel (OTC) — Pinworm medicine (pyrantel pamoate) chewable tablets — Drug Facts (SPL effective 2026-07-27, version 1)↗[Public]
  • FDA Famciclovir — Famciclovir tablets — Prescribing Information (SPL effective 2026-07-21, version 1)↗[Public]
  • FDA Ofloxacin otic — Ofloxacin otic solution 0.3% — Prescribing Information (SPL effective 2026-09-15, version 10)↗[Public]
  • FDA Nexium — Nexium (esomeprazole magnesium) delayed-release capsules — Prescribing Information (SPL effective 2025-12-19, version 74)↗[Public]
  • FDA Lansoprazole — Lansoprazole delayed-release capsules — Prescribing Information (SPL effective 2022-03-01, version 26)↗[Public]
  • FDA Pepto-Bismol (OTC) — Pepto-Bismol (bismuth subsalicylate 525 mg/30 mL) — Drug Facts (SPL effective 2026-10-06, version 19)↗[Public]
  • FDA Senna (OTC) — Senna laxative (sennosides 8.6 mg) tablets — Drug Facts (SPL effective 2026-09-29, version 8)↗[Public]
  • FDA Docusate (OTC) — Docusate sodium 100 mg softgels — Drug Facts (SPL effective 2026-10-07, version 2)↗[Public]
  • FDA Metamucil (OTC) — Metamucil (psyllium husk) powder — Drug Facts (SPL effective 2026-10-02, version 22)↗[Public]
  • FDA Prochlorperazine — Prochlorperazine maleate tablets — Prescribing Information (SPL effective 2026-10-05, version 2)↗[Public]
  • FDA Advair Diskus — Advair Diskus (fluticasone propionate/salmeterol) — Prescribing Information (SPL effective 2026-03-26, version 32)↗[Public]
  • FDA Spiriva Respimat — Spiriva Respimat (tiotropium) inhalation spray — Prescribing Information (SPL effective 2026-08-17, version 16)↗[Public]
  • FDA QVAR RediHaler — QVAR RediHaler (beclomethasone dipropionate HFA) — Prescribing Information (SPL effective 2025-09-30, version 17)↗[Public]
  • FDA Mometasone nasal — Mometasone furoate nasal spray 50 mcg (OTC) — Drug Facts (SPL effective 2026-03-06, version 5)↗[Public]
  • FDA Azelastine nasal — Azelastine HCl nasal spray 205.5 mcg (OTC) — Drug Facts (SPL effective 2026-10-02, version 7)↗[Public]
  • FDA Oxymetazoline (OTC) — Oxymetazoline HCl 0.05% nasal spray — Drug Facts (SPL effective 2026-10-01, version 4)↗[Public]
  • FDA Benzonatate — Benzonatate capsules USP — Prescribing Information (SPL effective 2026-09-16, version 1)↗[Public]
  • FDA Prednisone — Prednisone tablets USP — Prescribing Information (SPL effective 2026-09-15, version 10)↗[Public]
  • FDA Medrol — Medrol (methylprednisolone) tablets — Prescribing Information (SPL effective 2025-11-14, version 25)↗[Public]
  • FDA Paroxetine — Paroxetine tablets USP — Prescribing Information (SPL effective 2026-08-21, version 1)↗[Public]
  • FDA Duloxetine — Duloxetine delayed-release capsules — Prescribing Information (SPL effective 2025-12-21, version 12)↗[Public]
  • FDA Fluvoxamine — Fluvoxamine maleate tablets — Prescribing Information (SPL effective 2026-09-11, version 16)↗[Public]
  • FDA Clomipramine — Clomipramine hydrochloride capsules USP — Prescribing Information (SPL effective 2025-12-26, version 10)↗[Public]
  • FDA Imipramine — Imipramine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-08-11, version 21)↗[Public]
  • FDA Oxcarbazepine — Oxcarbazepine tablets — Prescribing Information (SPL effective 2026-08-26, version 1)↗[Public]
  • FDA Cyclobenzaprine — Cyclobenzaprine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-05, version 1)↗[Public]
  • FDA Tizanidine — Tizanidine tablets — Prescribing Information (SPL effective 2026-09-18, version 15)↗[Public]
  • FDA Ropinirole — Ropinirole tablets — Prescribing Information (SPL effective 2026-09-02, version 22)↗[Public]
  • FDA Aricept — Aricept (donepezil hydrochloride) tablets — Prescribing Information (SPL effective 2021-12-30, version 33)↗[Public]
  • FDA Memantine — Memantine hydrochloride tablets USP — Prescribing Information (SPL effective 2025-06-23, version 2)↗[Public]
  • FDA Carbidopa-levodopa — Carbidopa and levodopa tablets USP — Prescribing Information (SPL effective 2026-07-09, version 21)↗[Public]
  • FDA Varenicline — Varenicline tablets — Prescribing Information (SPL effective 2026-09-21, version 4)↗[Public]
  • FDA Nicotine patch (OTC) — Nicotine transdermal system 21/14/7 mg — Drug Facts (SPL effective 2026-09-10, version 12)↗[Public]
  • FDA Nicotine gum (OTC) — Nicotine polacrilex gum 2/4 mg — Drug Facts (SPL effective 2026-10-02, version 2)↗[Public]
  • FDA Prazosin — Prazosin hydrochloride capsules USP — Prescribing Information (SPL effective 2026-10-08, version 5)↗[Public]
  • FDA Clonidine — Clonidine hydrochloride tablets USP — Prescribing Information (SPL effective 2026-09-30, version 5)↗[Public]
  • FDA Finasteride — Finasteride tablets 5 mg — Prescribing Information (SPL effective 2026-09-17, version 10)↗[Public]
  • FDA Sildenafil — Sildenafil citrate tablets — Prescribing Information (SPL effective 2026-05-13, version 4)↗[Public]
  • FDA Tadalafil — Tadalafil tablets — Prescribing Information (SPL effective 2025-03-01, version 9)↗[Public]
  • FDA Solifenacin — Solifenacin succinate tablets — Prescribing Information (SPL effective 2026-09-22, version 2)↗[Public]
  • FDA Tolterodine — Tolterodine tartrate tablets — Prescribing Information (SPL effective 2025-04-01, version 3)↗[Public]
  • FDA Phenazopyridine — Phenazopyridine HCl 99.5 mg urinary pain relief — Drug Facts (SPL effective 2026-10-06, version 1)↗[Public]
  • FDA Plan B One-Step — Plan B One-Step (levonorgestrel 1.5 mg) — Drug Facts (SPL effective 2023-01-31, version 5)↗[Public]
  • FDA Norethindrone — Norethindrone acetate tablets USP 5 mg — Prescribing Information (SPL effective 2026-01-29, version 10)↗[Public]
  • FDA Tranexamic acid — Tranexamic acid tablets 650 mg — Prescribing Information (SPL effective 2026-05-13, version 1)↗[Public]
  • FDA MetroGel vaginal — Metronidazole vaginal gel 0.75% — Prescribing Information (SPL effective 2026-10-01, version 1)↗[Public]
  • FDA Monistat 3 (OTC) — Monistat 3 (miconazole nitrate 200 mg) — Drug Facts (SPL effective 2026-09-24, version 4)↗[Public]
  • FDA Clomiphene — Clomiphene citrate tablets USP 50 mg — Prescribing Information (SPL effective 2026-07-16, version 1)↗[Public]
  • FDA Adapalene (OTC) — Adapalene 0.1% gel — Drug Facts (SPL effective 2026-09-22, version 4)↗[Public]
  • FDA Benzoyl peroxide — Benzoyl peroxide 10% acne cream — Drug Facts (SPL effective 2026-10-08, version 3)↗[Public]
  • FDA Clindamycin gel — Clindamycin phosphate gel USP 1% — Prescribing Information (SPL effective 2025-12-02, version 5)↗[Public]
  • FDA Triamcinolone cream — Triamcinolone acetonide cream USP 0.1% — Prescribing Information (SPL effective 2026-07-07, version 4)↗[Public]
  • FDA Clobetasol cream — Clobetasol propionate cream USP 0.05% — Prescribing Information (SPL effective 2023-12-29, version 12)↗[Public]
  • FDA Nystatin cream — Nystatin cream USP 100,000 units/g — Prescribing Information (SPL effective 2026-05-01, version 9)↗[Public]
  • FDA Acyclovir cream — Acyclovir cream 5% — Prescribing Information (SPL effective 2026-06-18, version 5)↗[Public]
  • FDA EpiPen — EpiPen / EpiPen Jr (epinephrine) auto-injector — Prescribing Information (SPL effective 2023-02-15, version 37)↗[Public]
  • FDA Carbamide peroxide — Carbamide peroxide 6.5% earwax removal drops — Drug Facts (SPL effective 2026-10-05, version 3)↗[Public]
  • FDA Chlordiazepoxide — Chlordiazepoxide HCl capsules USP — Prescribing Information (SPL effective 2026-05-05, version 1)↗[Public]
  • FDA Oxazepam — Oxazepam capsules USP — Prescribing Information (SPL effective 2025-09-22, version 1)↗[Public]
  • FDA Trifluoperazine — Trifluoperazine HCl tablets USP — Prescribing Information (SPL effective 2025-07-22, version 11)↗[Public]
  • FDA Perphenazine — Perphenazine tablets USP — Prescribing Information (SPL effective 2026-08-25, version 20)↗[Public]
  • FDA Trihexyphenidyl — Trihexyphenidyl HCl tablets USP — Prescribing Information (SPL effective 2024-02-02, version 10)↗[Public]
  • FDA Clozapine — Clozapine tablets USP — Prescribing Information (SPL effective 2026-05-11, version 1)↗[Public]
  • FDA Geodon — Geodon (ziprasidone) capsules — Prescribing Information (SPL effective 2025-01-13, version 50)↗[Public]
  • FDA Valproic acid sol. — Valproic acid oral solution 250 mg/5 mL — Prescribing Information (SPL effective 2025-01-24, version 22)↗[Public]
  • FDA Cimetidine — Cimetidine tablets USP — Prescribing Information (SPL effective 2022-11-30, version 12)↗[Public]
  • FDA Mylanta (OTC) — Mylanta (calcium carbonate / magnesium hydroxide / simethicone) — Drug Facts (SPL effective 2026-08-15, version 1)↗[Public]
  • FDA Librax (generic) — Chlordiazepoxide HCl and clidinium bromide capsules — Prescribing Information (SPL effective 2025-09-03, version 5)↗[Public]
  • FDA Mesalamine DR — Mesalamine delayed-release tablets 800 mg — Prescribing Information (SPL effective 2026-07-14, version 9)↗[Public]
  • FDA Ursodiol — Ursodiol capsules USP 300 mg — Prescribing Information (SPL effective 2023-07-31, version 15)↗[Public]
  • FDA APAP-codeine — Acetaminophen and codeine phosphate tablets USP — Prescribing Information (SPL effective 2026-09-18, version 10)↗[Public]
  • FDA Albuterol syrup — Albuterol sulfate syrup 2 mg/5 mL — Prescribing Information (SPL effective 2025-12-17, version 1)↗[Public]
  • FDA Albuterol neb — Albuterol sulfate inhalation solution 0.63/1.25 mg — Prescribing Information (SPL effective 2026-04-30, version 10)↗[Public]
  • FDA Ampicillin — Ampicillin capsules USP — Prescribing Information (SPL effective 2025-08-14, version 4)↗[Public]
  • FDA Dicloxacillin — Dicloxacillin sodium capsules USP — Prescribing Information (SPL effective 2022-06-22, version 12)↗[Public]
  • FDA Gentamicin inj. — Gentamicin sulfate injection USP 40 mg/mL — Prescribing Information (SPL effective 2026-05-20, version 22)↗[Public]
  • FDA FeverAll Jr (OTC) — FeverAll Jr. Strength (acetaminophen 325 mg) suppositories — Drug Facts (SPL effective 2026-09-03, version 8)↗[Public]
  • FDA Fe-Vite drops — Fe-Vite iron oral solution (ferrous sulfate, 15 mg iron/mL) — supplement label (SPL effective 2026-04-10, version 6)↗[Public]
  • FDA Diazepam rectal gel — Diazepam rectal gel 5 mg/mL — Prescribing Information (SPL effective 2026-05-28, version 3)↗[Public]
  • FDA Ketorolac inj. — Ketorolac tromethamine injection — Prescribing Information (SPL effective 2026-09-29, version 3)↗[Public]
  • FDA Metoclopramide inj. — Metoclopramide injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 1)↗[Public]
  • FDA Dexamethasone inj. — Dexamethasone sodium phosphate injection 4 mg/mL — Prescribing Information (SPL effective 2026-08-31, version 1)↗[Public]
  • FDA Solu-Cortef — Solu-Cortef (hydrocortisone sodium succinate) — Prescribing Information (SPL effective 2026-09-29, version 31)↗[Public]
  • FDA Promethazine inj. — Promethazine HCl injection 25 mg/mL — Prescribing Information (SPL effective 2025-12-18, version 3)↗[Public]
  • FDA Diazepam inj. — Diazepam injection 5 mg/mL — Prescribing Information (SPL effective 2026-08-19, version 2)↗[Public]
  • FDA Epinephrine 1 mg/mL — Epinephrine injection 1 mg/mL — Prescribing Information (SPL effective 2026-09-23, version 6)↗[Public]
  • FDA Thiamine inj. — Thiamine hydrochloride injection 100 mg/mL — Prescribing Information (SPL effective 2026-10-06, version 2)↗[Public]
  • FDA Levora — Levora 0.15/30 (levonorgestrel/ethinyl estradiol) — Prescribing Information (SPL effective 2025-07-24, version 10)↗[Public]
  • FDA Crinone — Crinone (progesterone gel) 4%/8% — Prescribing Information (SPL effective 2024-05-21, version 11)↗[Public]
  • FDA Cabergoline — Cabergoline tablets 0.5 mg — Prescribing Information (SPL effective 2026-06-22, version 4)↗[Public]
  • FDA Bromocriptine — Bromocriptine mesylate tablets/capsules — Prescribing Information (SPL effective 2026-07-27, version 4)↗[Public]
  • FDA Fluorometholone eye — Fluorometholone ophthalmic suspension 0.1% — Prescribing Information (SPL effective 2026-08-12, version 8)↗[Public]
  • FDA Artificial tears — Artificial tears (dextran/glycerin/hypromellose) — Drug Facts (SPL effective 2026-07-07, version 5)↗[Public]
  • FDA Ciprofloxacin otic — Ciprofloxacin otic solution 0.2% — Prescribing Information (SPL effective 2026-09-22, version 2)↗[Public]
  • FDA Cipro HC otic — Ciprofloxacin/hydrocortisone otic suspension — Prescribing Information (SPL effective 2026-05-29, version 1)↗[Public]
  • FDA Nizoral shampoo — Nizoral A-D (ketoconazole 1%) shampoo — Drug Facts (SPL effective 2026-09-10, version 8)↗[Public]
  • FDA Rogaine women (OTC) — Women’s Rogaine (minoxidil 5% foam) — Drug Facts (SPL effective 2024-11-13, version 6)↗[Public]
  • FDA Calamine lotion — Calamine lotion (calamine 8% / zinc oxide 8%) — Drug Facts (SPL effective 2026-01-29, version 3)↗[Public]
  • FDA Urea 20% cream — Uracin (urea 20%) cream — product label (SPL effective 2026-10-06, version 6)↗[Public]

UK SmPC (eMC / MHRA)

  • UK SmPC Metoclopramide — Metoclopramide hydrochloride 5 mg/5 ml Oral Solution — Summary of Product Characteristics (Revised 26/01/2026)↗[Public]
  • UK SmPC Domperidone — Domperidone 1 mg/ml Oral Suspension — Summary of Product Characteristics (Revised 04/11/2025)↗[Public]
  • UK SmPC Neoclarityn — NeoClarityn (desloratadine) 0.5 mg/ml Oral Solution — Summary of Product Characteristics (Revised 01 January 2021)↗[Public]
  • UK SmPC Piriton — Piriton Syrup (chlorphenamine maleate 2 mg/5 ml) — Summary of Product Characteristics (Revised 14 April 2023)↗[Public]
  • UK SmPC Sytron — Sytron 27.5 mg iron per 5 ml Oral Solution (sodium feredetate) — Summary of Product Characteristics (Revised 01/05/2025)↗[Public]
  • UK SmPC Thorens D3 — THORENS 10 000 I.U./ml oral drops (colecalciferol) — Summary of Product Characteristics (Revised 13 January 2022)↗[Public]
  • UK SmPC Prednisolone — Prednisolone 10 mg/ml Oral Solution — Summary of Product Characteristics (Revised 11/2025)↗[Public]
  • UK SmPC Movicol Paed — MOVICOL Paediatric Chocolate flavour 6.8 g powder for oral solution — Summary of Product Characteristics (Revised 11/03/2025)↗[Public]
  • UK SmPC Budesonide neb — Budesonide 0.5 mg nebuliser suspension — Summary of Product Characteristics (Revised 14/05/2024)↗[Public]
  • UK SmPC Diamicron 80 — Diamicron 80 mg Tablets — Summary of Product Characteristics (Revised 02/2020)↗[Public]
  • UK SmPC Gliclazide MR 30 — Gliclazide Krka 30 mg modified-release tablets — Summary of Product Characteristics (Revised 24/10/2023)↗[Public]
  • UK SmPC Serc 8 — Serc-8 (betahistine dihydrochloride 8 mg) tablets — Summary of Product Characteristics (Revised November 2025)↗[Public]
  • UK SmPC Buscopan — Buscopan 10 mg Tablets — Summary of Product Characteristics (Revised 22/09/2025)↗[Public]
  • UK SmPC Colofac — Colofac (mebeverine) 135 mg Coated Tablets — Summary of Product Characteristics (Revised Jun 2025)↗[Public]
  • UK SmPC Fucidin cream — Fucidin 20 mg/g Cream — Summary of Product Characteristics (Revised 01 June 2026)↗[Public]
  • UK SmPC Canesten cream — Canesten (clotrimazole 1%) Cream — Summary of Product Characteristics (Revised 07/06/2022)↗[Public]
  • UK SmPC Canesten pess. — Canesten Thrush Pessary 500 mg — Summary of Product Characteristics (Revised 06/06/2023)↗[Public]
  • UK SmPC Folic acid 5 mg — Folic Acid Tablets 5 mg — Summary of Product Characteristics (Revised 20/05/2026)↗[Public]
  • UK SmPC Ferrous sulfate — Ferrous Sulfate Tablets 200 mg — Summary of Product Characteristics (Revised 01/09/2021)↗[Public]
  • UK SmPC Hydroxocobalamin — Hydroxocobalamin 1 mg/ml Solution for Injection — Summary of Product Characteristics (Revised 23/01/2024)↗[Public]
  • UK SmPC Adcal-D3 — Adcal-D3 chewable tablets — Summary of Product Characteristics (Revised 04/2025)↗[Public]
  • UK SmPC Indapamide — Indapamide 2.5 mg Tablets — Summary of Product Characteristics (Revised 02/04/2026)↗[Public]
  • UK SmPC Voltarol amp. — Voltarol Ampoules (diclofenac sodium 75 mg/3 mL) — Summary of Product Characteristics (Revised 9 September 2025)↗[Public]
  • UK SmPC Buscopan amp. — Buscopan Ampoules (hyoscine butylbromide 20 mg/mL) — Summary of Product Characteristics (Revised 11/12/2025)↗[Public]
  • UK SmPC Metronidazole — Metronidazole 200 mg/5 ml Oral Suspension — Summary of Product Characteristics (Revised 20/06/2023)↗[Public]
  • UK SmPC Betnesol drops — Betnesol Eye, Ear and Nose Drops 0.1% — Summary of Product Characteristics (Revised 11/01/2021)↗[Public]
  • UK SmPC Chloramphenicol — Minims Chloramphenicol 0.5% eye drops — Summary of Product Characteristics (Revised see eMC)↗[Public]
  • UK SmPC Fucidin H — Fucidin H cream (fusidic acid 2% + hydrocortisone 1%) — Summary of Product Characteristics (Revised see eMC)↗[Public]

EU SmPC (EMA)

No sources of this type recorded yet.

Published guideline

  • FDA DSC 2018 — FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older (Safety Announcement 2018-01-11)↗[Public]
  • CPS AOM 2016 — Management of acute otitis media in children six months of age and older. Le Saux N, Robinson JL. Paediatr Child Health 2016;21(1):39-44 (Reaffirmed 2024-11-21)↗[Public]
  • CPS Ondansetron 2018 — Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Cheng A; updated by Doré-Bergeron MJ, Chauvin-Kimoff L. Practice point, posted 2018-12-19↗[Public]
  • CPS Croup — Acute management of croup in the emergency department. Ortiz-Alvarez O. Practice point; posted 2017-05-24, updated 2026-03-06↗[Public]
  • WHO/USAID Diarrhoea 2005 — Diarrhoea Treatment Guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers (January 2005)↗[Public]
  • WHO eLENA Zinc — Zinc supplementation in the management of diarrhoea (WHO e-Library of Evidence for Nutrition Actions) (Last updated 2023-08-09)↗[Public]
  • WHO Fact sheet — Diarrhoeal disease — WHO fact sheet (7 March 2024)↗[Public]

Licensed reference (medical school)

  • Licensed ref — Licensed pediatric dosing reference (pending, via medical school license)[License pending]

Iranian leaflet (IFDA)

No sources of this type recorded yet.

Reference textbook

No sources of this type recorded yet.

MedlinePlus (U.S. National Library of Medicine)

  • MedlinePlus — MedlinePlus Medical Encyclopedia: Ear infection - acute (Review date 2025-01-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Strep throat (Review date 2025-07-03)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Community-acquired pneumonia in adults (Review date 2024-08-19)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Sinusitis (Review date 2026-04-29)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic rhinitis (Review date 2026-01-20)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Constipation in infants and children (Review date 2024-07-31)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Autism spectrum disorder (Review date 2025-04-06)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Schizophrenia (Review date 2024-07-17)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Bipolar disorder (Review date 2024-07-17)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Juvenile idiopathic arthritis (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Cellulitis (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Impetigo (Review date 2024-10-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Osteomyelitis (Review date 2026-03-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Urinary tract infection - children (Review date 2026-01-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Gonorrhea (Review date 2025-05-22)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Pertussis (Review date 2025-07-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Shigellosis (Review date 2026-03-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Pneumocystis jirovecii pneumonia (Review date 2025-12-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Amebiasis (Review date 2024-08-29)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Peptic ulcer (Review date 2025-04-21)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Gastroesophageal reflux disease - children (Review date 2024-07-31)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Giardia infection (Review date 2026-03-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Cryptosporidium enteritis (Review date 2026-03-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Viral gastroenteritis (stomach flu) (Review date 2026-04-27)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Hives (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Asthma in children (Review date 2025-04-06)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Thrush - children and adults (Review date 2025-08-05)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Irritable bowel syndrome (Review date 2025-04-21)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Amebic liver abscess (Review date 2025-05-12)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Acute bronchitis (Review date 2026-02-27)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Flu (Review date 2024-07-23)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Chickenpox (Review date 2025-07-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Scabies (Review date 2025-11-20)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Pinworms (Review date 2024-10-09)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Ascariasis (Review date 2024-11-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Hookworm infection (Review date 2025-08-05)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Whipworm infection (Review date 2024-11-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Cysticercosis (Review date 2025-12-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Iron deficiency anemia (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Rickets (Review date 2024-07-16)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Croup (Review date 2026-01-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Type 2 diabetes (Review date 2025-01-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Hypothyroidism (Review date 2024-07-21)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoarthritis (Review date 2026-04-09)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Rheumatoid arthritis (Review date 2025-01-28)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Attention deficit hyperactivity disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Major depression (Review date 2025-04-19)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Obsessive-compulsive disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Panic disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Post-traumatic stress disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Social anxiety disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Bulimia (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Tourette syndrome (Review date 2026-01-27)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Epilepsy (Review date 2025-04-16)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Migraine (Review date 2025-02-11)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Generalized anxiety disorder (Review date 2025-04-19)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Seasonal affective disorder (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Trigeminal neuralgia (Review date 2026-05-04)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Psychosis (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Essential tremor (Review date 2026-05-04)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Conjunctivitis or pink eye (Review date 2024-07-09)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Allergic conjunctivitis (Review date 2024-07-22)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Common cold (Review date 2025-01-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Heart failure (Review date 2024-07-14)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Atrial fibrillation and atrial flutter (Review date 2025-01-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Hyperthyroidism (Review date 2024-07-21)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Type 1 diabetes (Review date 2025-01-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Vaginal yeast infection (Review date 2025-08-18)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Fungal nail infection (Review date 2024-10-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Herpes - oral (Review date 2025-07-03)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Genital herpes (Review date 2025-07-03)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Shingles (Review date 2024-11-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Syphilis (Review date 2024-08-29)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Meningitis (Review date 2024-11-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Typhoid fever (Review date 2025-05-12)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Gout (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Fibromyalgia (Review date 2025-01-28)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Insomnia (Review date 2026-05-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Meniere disease (Review date 2025-07-17)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Enlarged prostate (Review date 2025-07-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Urge incontinence (Review date 2025-07-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Chronic obstructive pulmonary disease (COPD) (Review date 2025-04-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the body (Review date 2024-10-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Tinea versicolor (Review date 2024-10-14)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Seborrheic dermatitis (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Burns (Review date 2026-04-09)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Absent menstrual periods - secondary (Review date 2026-05-29)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Abnormal uterine bleeding (Review date 2024-10-15)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Osteoporosis (Review date 2025-01-28)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Deep vein thrombosis (Review date 2025-04-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Swimmer's ear (Review date 2024-07-16)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Trichomoniasis (Review date 2024-11-10)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Ringworm of the scalp (Review date 2024-10-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Helicobacter pylori infection (Review date 2026-01-13)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Alzheimer disease (Review date 2026-01-27)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Parkinson disease (Review date 2026-01-27)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Restless legs syndrome (Review date 2025-07-17)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Erection problems (Review date 2025-10-01)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Endometriosis (Review date 2025-05-22)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Acne (Review date 2025-08-02)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Psoriasis (Review date 2024-08-05)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Ear wax (Review date 2026-04-29)↗[Public]
  • MedlinePlus — MedlinePlus Medical Encyclopedia: Anaphylaxis (Review date 2026-01-20)↗[Public]

Pharmacy website (secondary, unreliable)

  • Salamati24 Corizan — کوریزان کودکان سرماخوردگی و آنفلوانزا — صفحه دارو↗[Public]
  • Adorateb Corizan — شربت کوریزان سرماخوردگی و آنفولانزا — صفحه محصول↗[Public]
  • Darooyab Ketotifen — کتوتیفن — موارد مصرف، دوز، اشکال دارویی↗[Public]
  • Darooyab Theophylline G — تئوفیلین جی — دارویاب↗[Public]
  • Beytoote Bromhexine — کاربردهای شربت برم هگزین و عوارض و دوز مصرفی آن↗[Public]
  • Darooyab Biperiden — بی‌پریدن — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[Public]
  • Darooyab Dydrogesterone — دیدروژسترون — موارد مصرف، اشکال دارویی، نام‌های تجاری↗[Public]
  • Darooyab Aluminium MGS — آلومینیوم ام جی اس — موارد مصرف، اشکال دارویی↗[Public]
  • Darooyab Vitamin A+D — ویتامین آ + د خوراکی — موارد مصرف، اشکال دارویی↗[Public]
  • Darooyab Eternavit AD — قطره آ د اترنیویت ۳۰ میلی‌لیتر↗[Public]
  • Darooyab B Complex — ویتامین ب کمپلکس — موارد مصرف، اشکال دارویی↗[Public]
  • Darooyab Contracep. HD — کنتراسپتیو اچ دی — موارد مصرف، اشکال دارویی↗[Public]
  • Darooyab Aburaihan — داروسازی ابوریحان — فهرست فرآورده‌ها (شیاف ایبوپروفن)↗[Public]

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav